Comparative Study Between Botulinum Toxin-A Injection and Shock Waves on Hypertrophic Scars in Hand-burned Children
NCT06174155 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2026-02-04
Summary
PURPOSE: The study aims to compare study between Botulinum toxin-A injection and shock waves therapy on hypertrophic scars in hand-burned children.
BACKGROUND: Burn injuries can cause significant physical and psychological distress, especially when they result in hypertrophic scarring. In children, who are particularly vulnerable to these injuries, it is important to accurately assess the severity of these scars and their impact on functionality.
HYPOTHESES: There is no significant difference between the combined effect of the traditional physical therapy program with botulinum toxin-A injection and the traditional physical therapy program with shock waves therapy on improving wrist extension, ulnar deviation, radial deviation, hand grip strength, and severity of the scar on hypertrophic scars in hand-burned children.
Conditions
- Hand-burned Children
Interventions
- OTHER
-
physical therapy treatment
The control group will receive the physical therapy program and conduct five times per week over four consecutive weeks under the supervision of a physical rehabilitation specialist. The primary focus of the program was to improve scar malleability, lengthen muscles and tendons, enhance joint mobility, and to restore functionality. Each session lasted almost for 45 minutes and consisted of therapeutic paraffin application; deep tissue massaging (5 minutes); stretching exercises; active ROM exercises.
- OTHER
-
Botulinum toxin-A injection in addition to physical therapy program
Two injection procedures will be used. The first is an EMG-guided BTX-A administration (Botox®, Allergan PLC, Dublin, Ireland) that will be localized to the motor endplate zone of the wrist flexors, radial and ulnar deviators. The second is a meso-injection procedure, where the BTX-A will be injected subdermal, intradermal, and into the scar (around the periphery and into the center).
- OTHER
-
shock wave therapy in addition to physical therapy program
After wound and skin graft healing (\~ 90 days post-surgery), the unfocused shockwave will be applied to the site of burn injury on the volar aspect of the hand of the subjects and will allocate to the shock wave therapy intervention arm. The treatment will be delivered using a portable shockwave device (Zimmer enPuls, EMS physio Ltd, Germany).
Sponsors & Collaborators
-
Cairo University
lead OTHER
Principal Investigators
-
Reham Alsakhawi · Assistant Professor
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 6 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-12-15
- Primary Completion
- 2024-03-05
- Completion
- 2025-06-20
Countries
- Egypt
Study Locations
More Related Trials
-
Clinical Evaluation of the Efficacy OF Botulinum Toxin A for Improving Facial Scars
NCT04756882 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy of Extracorporeal Shock Wave Therapy on Spasticity
NCT06225024 ·Status: COMPLETED ·Phase: NA
-
Ultrasound-Guided Versus Anatomically Guided Botulinum Toxin Injection in Spasticity in Adults in Tanta University Hospitals
NCT06941883 ·Status: COMPLETED
-
Botulinum Toxin Injection in Reducing Lip Scar Following Cleft Lip Repair
NCT05559281 ·Status: COMPLETED ·Phase: NA
-
IDB Injection Combined With PTNS for Managing Children With OAB Not Responding to Monotherapy
NCT05911594 ·Status: COMPLETED ·Phase: NA
-
Comparing the Radial Extracorporeal Shock Waves and Botulinum Toxin Injection for Spasticity
NCT03131791 ·Status: COMPLETED ·Phase: NA
-
Botulinum Toxin Injection Versus Anal Myectomy in Management of Idiopathic Constipation
NCT02361749 ·Status: UNKNOWN ·Phase: PHASE4
-
Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT
NCT02400619 ·Status: COMPLETED ·Phase: PHASE1
-
The Use of Microneedles With Topical Botulinum Toxin for Treatment of Palmar Hyperhidrosis
NCT03203174 ·Status: COMPLETED ·Phase: PHASE1
-
Acupuncture, Dry Needle and Botox Injection in Management of Patient With Myofascial Pain Dysfunction Syndrome
NCT06013644 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Delivery of Intravesical Botulinum Toxin A Using Low Energy Shock Waves in Treatment of Overactive Bladder: A Feasibility Study
NCT03385460 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Effect of Botulinum Toxin Type-A Injection Prior to Surgical Correction of Complete Unilateral Cleft Lip Repair by Modified Millard Cheiloplasty
NCT03047499 ·Status: UNKNOWN
-
Botulinum Toxin to Improve Cosmesis of Primary Cleft Lip Repair
NCT02247193 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Mixed Urinary Incontinence Symptoms Before and After Treatment With Botox and Bulkamid
NCT02815046 ·Status: COMPLETED
-
Split-face Study: Cosmetic Botulinum Toxin Type A Injection Under Electromyography-guidance Versus Conventional Palpation Technique
NCT05517538 ·Status: COMPLETED ·Phase: NA
-
Does ESWT With BoNTA Treatment Improve Outcomes When Compared to Standard Management for Upper Limb Spasticity Patient.
NCT05226637 ·Status: RECRUITING ·Phase: NA
-
Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia
NCT02334683 ·Status: COMPLETED ·Phase: NA
-
Randomized Controlled Trial Examining the Efficacy of Botulinum Toxin in Biopsy Scar Minimization
NCT05478551 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
CLINICAL EFFECT OF BOTULINUM TOXIN TYPE A IN TREATMENT OF SPASTICITY
NCT04673240 ·Status: UNKNOWN
-
Treatment of Frostbite Sequelae With Botulinum Toxin A
NCT06460194 ·Status: WITHDRAWN ·Phase: PHASE2
-
Mandibular Splint vs Botox Injection in Lateral Pterygoid on Cervical Muscle Activity in Patients With Temporomandibular Disorders
NCT06553950 ·Status: RECRUITING ·Phase: NA
-
Optimal Dose of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity
NCT02358005 ·Status: UNKNOWN ·Phase: PHASE4
-
Botulinum Toxin Type A for Neuroma Pain
NCT01374191 ·Status: WITHDRAWN ·Phase: PHASE2
-
Botulinum Toxin A for the Treatment of Keratoconus
NCT01691651 ·Status: COMPLETED ·Phase: NA
-
Treatment of Hypertrophic Scars With Intradermal Botox
NCT03631368 ·Status: UNKNOWN ·Phase: PHASE2